We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$211M
AUM Growth
+$6.73M
Cap. Flow
-$2.71M
Cap. Flow %
-1.29%
Top 10 Hldgs %
63.4%
Holding
52
New
2
Increased
11
Reduced
33
Closed
3

Top Buys

Rank Stock Value
1
FIVE icon
Five Below
FIVE
+$4.17M
2
DIS icon
Walt Disney
DIS
+$3.98M
3
NVDA icon
NVIDIA
NVDA
+$232K
4
AEP icon
American Electric Power
AEP
+$200K
5
NEE icon
NextEra Energy
NEE
+$155K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.96M
2
BIIB icon
Biogen
BIIB
+$2.21M
3
GILD icon
Gilead Sciences
GILD
+$710K
4
ALXN
Alexion Pharmaceuticals
ALXN
+$537K
5
SBUX icon
Starbucks
SBUX
+$343K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.72%
2 Technology 26.12%
3 Healthcare 23.31%
4 Communication Services 13.52%
5 Industrials 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIDU icon
26
Baidu
BIDU
$35.8B
$1.61M 0.76%
14,100
-314
-2% -$44.7K
BA icon
27
Boeing
BA
$167B
$1.49M 0.7%
4,305
-207
-5% -$75.5K
HD icon
28
Home Depot
HD
$335B
$1.21M 0.57%
5,566
+143
+3% +$28.5K
NEE icon
29
NextEra Energy
NEE
$185B
$1.17M 0.55%
22,300
+3,152
+16% +$155K
NSC icon
30
Norfolk Southern
NSC
$77.1B
$829K 0.39%
4,365
-215
-5% -$42.6K
ABT icon
31
Abbott
ABT
$182B
$815K 0.39%
9,286
-1,165
-11% -$91.7K
JNJ icon
32
Johnson & Johnson
JNJ
$641B
$660K 0.31%
5,046
+65
+1% +$9K
LLY icon
33
Eli Lilly
LLY
$1.07T
$603K 0.29%
5,568
-125
-2% -$14.7K
PFE icon
34
Pfizer
PFE
$141B
$577K 0.27%
14,120
+395
+3% +$15.7K
MRK icon
35
Merck
MRK
$323B
$521K 0.25%
6,699
-84
-1% -$6.43K
BMY icon
36
Bristol-Myers Squibb
BMY
$128B
$491K 0.23%
10,832
-839
-7% -$39.1K
JPM icon
37
JPMorgan Chase
JPM
$947B
$480K 0.23%
4,134
-40
-1% -$4.41K
T icon
38
AT&T
T
$167B
$464K 0.22%
17,983
-185
-1% -$4.44K
PAYX icon
39
Paychex
PAYX
$41.1B
$448K 0.21%
5,180
– –
COST icon
40
Costco
COST
$422B
$407K 0.19%
1,448
-7
-0.5% -$1.75K
NUE icon
41
Nucor
NUE
$56.4B
$307K 0.15%
5,461
-25
-0.5% -$1.37K
TROW icon
42
T. Rowe Price
TROW
$25.5B
$304K 0.14%
2,640
-110
-4% -$11.6K
MSFT icon
43
Microsoft
MSFT
$2.89T
$288K 0.14%
2,037
+150
+8% +$19K
CAT icon
44
Caterpillar
CAT
$402B
$262K 0.12%
1,974
– –
VZ icon
45
Verizon
VZ
$198B
$249K 0.12%
4,369
-300
-6% -$17.3K
DE icon
46
Deere & Co
DE
$169B
$245K 0.12%
1,440
– –
DUK icon
47
Duke Energy
DUK
$100B
$241K 0.11%
2,776
+90
+3% +$7.96K
CVX icon
48
Chevron
CVX
$378B
$218K 0.1%
1,765
-30
-2% -$3.63K
AEP icon
49
American Electric Power
AEP
$72.7B
$206K 0.1%
+2,320
New +$200K
BIIB icon
50
Biogen
BIIB
$29.5B
– –
-9,342
Closed -$2.21M
1
2
3

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
KPWG
KFA Private Wealth Group Tysons, Virginia $417M AUM 16.82% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return

Bender Robert & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Bender Robert & Associates held 52 positions worth $211M, up 3.3% from $204M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Bender Robert & Associates's Q2 2019 filing shows 2 new, 11 increased, 33 reduced and 3 closed positions. Its largest new stake was Five Below: 31,662 shares worth $3.85M. The largest sale was Celgene Corp, an estimated $4.96M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, up from 29% a quarter earlier, followed by Technology and Healthcare.

  • Bender Robert & Associates's largest Q2 2019 buy was Five Below: 31,662 shares worth $3.85M.
  • Bender Robert & Associates added most to Walt Disney in Q2 2019, an estimated $3.98M increase.
  • Bender Robert & Associates's biggest Q2 2019 reduction was Gilead Sciences, cutting an estimated $710K.
  • Bender Robert & Associates fully exited Celgene Corp in Q2 2019, selling an estimated $4.96M.
  • Bender Robert & Associates's ten largest holdings make up 63% of its $211M portfolio in Q2 2019.
  • Bender Robert & Associates opened 2 new positions and closed 3 in Q2 2019.
  • Bender Robert & Associates's portfolio value rose 3.3% quarter-over-quarter to $211M.

Based on Bender Robert & Associates's 13F filing for Q2 2019, filed 30 Jul 2019.